https://www.selleckchem.com/pr....oducts/Cediranib.htm
98 together with 91.7% sensitivity and 93.1% specificity, which is better than individual markers (AUC were 0.76, 0.84, 0.65, 0.82, and 0.85, respectively) (P = 0.001). 0.05). However, expression intensity of CD117 (P = 0.002), CD13 (P less then 0.001), CD35 (P less then 0.001), CD64 (P less then 0.001), and MPO (P less then 0.001) in APL are significantly higher while CD56 (P = 0.049) is lower than in non-APL subjects. The Bayesian Model Averaging (BMA) analysis identified CD117 (≥ 49% events), CD13 (≥ 88% events), CD56 (≤ 2
Like
Comment
Share
